Transcatheter Versus Standard Surgical Mitral Valve Operation for Secondary Mitral Regurgitation
Key facts
- Who runs it
- Centre Cardiologique du Nord
- Where
- France2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Enrolling by invitation
- People taking part
- 600 people, planned
- Started
- 1 Jun 2017
- Expected to end
- 30 Dec 2026
- Type of study
- Observational, 4 groups
- Treatments tested
- Trancatheter Edge to Edge Repair
- Mitral Valve Replacement
- Restrictive Mitral Annuloplastie
- Restrictive Mitral Annuloplastie/Subvalvular Repair
- Record updated
- 19 May 2026
Who can take part
- Age
- 18 years to 90 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Adult
- Ischemic NoIschemic cardiomyopathy
- EROA> 0,2 cm2 or Regurgitant Volume > 30 ml (ESC guidelines)
- EROA ≥ 0.4 cm2 with tethering (ACC/AHA)
- MR Grade 3/4
- Eligible for TEE, surgical repair and replacement of mitral valve
- Coronary artery disease with or without the need for coronary revascularization
- Average value LVEDD 62 mm LVEF 42%
Who cannot take part
- Any echocardiographic evidence of structural (chordal or leaflet) mitral-valve disease
- Pediatric
- ruptured papillary
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 90 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The mechanical intervention is treating secondary mitral regurgitation (SMR) which may be performed using the standard open surgical approach or transcatheter edge to edge repair (TEER). The key question of this study is to establish the difference in left ventricular reverse remodeling after adjustment for death, as assessed by means of the left ventricular end-systolic dimension(LVESD), all-cause and cause-specific (cardiac vs noncardiac) mortality in patients who received the TEER vs the standard surgical procedure for SMR.
The 4 groups in the trial
- Transcatheter Edge to Edge Repair
TEER procedure is performed by apposing the edges of the anterior and posterior leaflet (edge-to-edge) of MV. If the use of one MitraClip device does not result in sufficient reduction in mitral regurgitation, a second MitraClip device may be used to reduce MR optimizing the procedure.
Treatment: Trancatheter Edge to Edge Repair
- Mitral Valve Replacement
Mitral-valve replacement includes complete preservation of the subvalvular apparatus to avoid dilation of the left ventricle over time. The technique of preservation, type of prosthetic valve implanted, and technique of suture placement has been chosen according to the preference of the surgeons. In SMR due to ischemic cardiomyopathy, CABG operation(Revascularization) is required
- Restrictive Mitral Annuloplasty
RMA may be performed with the use of complete rigid or semi-rigid annuloplasty ring which has been downsized for the annulus diameter. Since patients who received RMA have coronary artery lesions, a CABG operation is useful to ensure favorable remodeling of the left ventricle.
Treatment: Restrictive Mitral Annuloplastie
- Restrictive Mitral Annuloplastie Plus Subvalvular Repair
RMA may be associated with the use of a subvalvular repair (SVR). The SVR permits the approximation or the relocation of papillary muscles which is displaced by post infarction scar formation. In patients who received SVR due to ischemic cardiomyopathy CABG operation is required
Treatment: Restrictive Mitral Annuloplastie/Subvalvular Repair
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Transcatheter Edge to Edge Mitral Valve Repair Versus Standard Surgical Mitral Valve Operation for Secondadry Mitral Regurgitation
- Criteria questions
- Built from NCT05090540, who can take part
- Publications
- Study protocol for an international registry observational study evaluating clinical outcomes of transcatheter versus standard surgical mitral valve operation for secondary mitral regurgitation: the TEERMISO study.BMJ open, 2025
- A Protocol Investigation Comparing Transcatheter Repair with the Standard Surgical Procedure for Secondary Mitral Regurgitation.Journal of clinical medicine, 2024
- Record updated
- 19 May 2026